- Home
- NL
as 07-26-2024 4:00pm EST
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
Upcoming Earnings Alert:
Get ready for potential market movements as NL Industries Inc. NL prepares to release earnings report on 31 Jul 2024.
| Founded: | 1891 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 314.5M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 41.4K |
| Analyst Decision: | Sell | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.23 | EPS Growth: | 35.29 |
| 52 Week Low/High: | $4.46 - $8.93 | Next Earning Date: | 07-31-2024 |
| Revenue: | $158,107,000 | Revenue Growth: | -4.56% |
| Revenue Growth (this year): | 6.01% | Revenue Growth (next year): | 2.41% |
Latest NL Industries Inc. News
NL Breaking Stock News: Dive into NL Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 days ago
Returns At NL Industries (NYSE:NL) Appear To Be Weighed Down
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
2 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
AFP
2 months ago
New Zealand scraps plan to tax livestock burps, farts
The Wall Street Journal
2 months ago
ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
Business Wire
2 months ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
Bloomberg
2 months ago
UK Unemployment Rises in Sign Inflationary Pressures Cool
Compare NL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NL NL Industries Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.